NDC 70326-101

Plalab Placenta Peeling

Juglans Regia Shell

Plalab Placenta Peeling is a Topical Gel in the Human Otc Drug category. It is labeled and distributed by Renocell Co., Ltd. The primary component is Juglans Regia Shell.

• Product ID: 70326-101_637c1170-1d65-4ff5-ad0e-9d108ea78b42
• NDC: 70326-101
• Product Type: Human Otc Drug
• Proprietary Name: Plalab Placenta Peeling
• Generic Name: Juglans Regia Shell
• Dosage Form: Gel
• Route of Administration: TOPICAL
• Marketing Start Date: 2015-12-22
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: RENOCELL Co., Ltd
• Substance Name: JUGLANS REGIA SHELL
• Active Ingredient Strength: 0 1/80mL
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 70326-101-02

1 TUBE in 1 PACKAGE (70326-101-02) > 80 mL in 1 TUBE (70326-101-01)

• Marketing Start Date: 2015-12-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70326-101-01 [70326010101]

Plalab Placenta Peeling GEL

• Marketing Category: unapproved drug other
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-12-22

NDC 70326-101-02 [70326010102]

Plalab Placenta Peeling GEL

• Marketing Category: unapproved drug other
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-12-22
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
JUGLANS REGIA SHELL	.005 1/80mL

OpenFDA Data

• SPL SET ID: 1c5417aa-10d2-4889-8828-0122bcffc1d4
• Manufacturer:
  • RENOCELL Co., Ltd
• UNII:
  • PJ10MT7VKA